Bioresorbable Collagen Implant Market Players:
- Allergan, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Zimmer Biomet Holdings, Inc.
- Galderma S.A.
- CollPlant Holdings Ltd.
- Collagen Matrix, Inc.
- Merz Pharma GmbH & Co. KGaA
- RegenLab SA
- Croma-Pharma GmbH
- Dr. Suwelack AG & Co. KG
- Mentor Worldwide LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of bioresorbable collagen implant is assessed at USD 1.48 billion.
The global bioresorbable collagen implant market size surpassed USD 1.38 billion in 2025 and is projected to witness a CAGR of over 8.2%, crossing USD 3.03 billion revenue by 2035.
By 2035, Asia Pacific is anticipated to capture a 37% revenue share in the bioresorbable collagen implant market, underpinned by the region’s expanding volume of orthopedic procedures and preference for minimally invasive techniques.
Key players in the market include Allergan, Inc., Zimmer Biomet Holdings, Inc., Galderma S.A., CollPlant Holdings Ltd., Collagen Matrix, Inc., Merz Pharma GmbH & Co. KGaA.
